S&P Global Market Intelligence’s Jeffrey Loo explains why he’s maintaining his Buy rating on Valeant Pharmaceuticals International (VRX) following reports it had rejected a takeover bid earlier this year:
According to unconfirmed reports, including the Wall Street Journal,Valeant rejected an unsolicited joint takeover bid from Takeda Pharmaceutical, the largest....More>>>
Memory chipmaker Micron’s (NASDAQ:MU) stock more than doubled over the past 12 months as tight memory supplies and high prices helped it post six straight quarters of double-digit sales growth.
That rally burned many bears, who assumed that Micron, a typically cyclical stock, would eventually tumble as memory chip supplies eclipsed market demand. Micron bulls have been arguing that....More>>>
Motilal Oswal’s research report on Tata Communications
High investment in frontloading growth opex/capex had hurt Data EBITDA. The management now expects its healthy funnel of orders to help maintain 12% Data revenue growth over 2-3 years (against 8% in the last three years). Data EBITDA margin (85% EBITDA contribution) should improve from 17% to 23% over FY18-21, leading to 410bp....More>>>
Analysts expect that Amedisys Inc (NASDAQ:AMED) will report $0.78 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Six analysts have provided estimates for Amedisys’ earnings. The lowest EPS estimate is $0.75 and the highest is $0.82. Amedisys reported earnings of $0.62 per share during the same quarter last year, which would indicate a positive year....More>>>
Raymond James analyst Christopher Raymond and team sayAbbVie (ABBV) is “not your father’s biotech company” as they initiate coverage with an Outperform rating:
Kevin Hagen for The Wall Street Journal
Initiating coverage of ABBV shares with an Outperform rating and an $82 price target as we think uncertainty over Humira’s intellectual property (IP) creates an....More>>>
European autos shares advanced and U.S. car stocks gained in pre-market trading after China said it will cut the import duty on passenger cars to 15 percent from the current 25 percent. Analysts see positive repercussions for automakers globally, with profits for German carmakers expected to rise.
Europe’s Stoxx 600 Automobiles & Parts Index rose 1.1 percent as of 2:12 p.m. CET,....More>>>
For the first time since I started investing, I have added a stock to my portfolio which is at its all-time high: Broadcom (NASDAQ:AVGO).
AVGO data by YCharts
Broadcom has got some safety issues, but I think they are controllable at the moment. The main reason I have added it to my portfolio is because it is a great combination of a value stock and a growth stock. It has a solid....More>>>
ICICI Direct’s research report on Timken India
Timken India reported strong operational numbers in Q4FY18. Revenues came in strong at | 345.4 crore, up 32.6% YoY. We had estimated 15% topline growth at | 300 crore Absolute EBITDA increased 22.4% YoY to | 46 crore. EBITDA margins came in at 13.3% vs. 14.4% YoY. Lower EBITDA margins were primarily due to a decline in gross margins....More>>>
Since 2012, congressional leaders have pushed to roll back banking regulations in an effort to turbocharge financial growth.
But according to Money Morning Capital Wave Strategist Shah Gilani, Congress has gone too far in its efforts to free up the financial industry.
In fact, there are strong indicators that Congress is actually setting the stage for the next financial crisis.....More>>>
Shares of Jubilant Foodworks touched 52-week high of Rs 2,668, rising over 2 percent intraday Tuesday as company reported strong numbers in the quarter ended March 2018.
It has posted a net profit of Rs 68.1 crore against Rs 6.7 crore in the same quarter of last year. The firm posted stellar growth of 27 percent in its revenues to Rs 780 crore against Rs 612.8 crore year on year.